|
UBE2Q1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.256610E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.917600E-03 |
| Normal-vs-Stage2 |
6.947000E-01 |
| Normal-vs-Stage3 |
3.210000E-02 |
| Normal-vs-Stage4 |
2.281400E-03 |
| Stage1-vs-Stage2 |
1.592410E-01 |
| Stage1-vs-Stage3 |
9.071400E-01 |
| Stage1-vs-Stage4 |
2.407800E-01 |
| Stage2-vs-Stage3 |
2.567600E-01 |
| Stage2-vs-Stage4 |
4.406500E-02 |
| Stage3-vs-Stage4 |
2.721600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.835900E-03 |
| Normal-vs-AfricanAmerican |
3.082100E-03 |
| Normal-vs-Asian |
1.399780E-03 |
| Caucasian-vs-AfricanAmerican |
3.339700E-02 |
| Caucasian-vs-Asian |
9.409600E-02 |
| AfricanAmerican-vs-Asian |
2.217200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.842090E-02 |
| Normal-vs-Female |
1.777540E-03 |
| Male-vs-Female |
8.670200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.544600E-03 |
| Normal-vs-Age(41-60Yrs) |
7.903800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.875900E-02 |
| Normal-vs-Age(81-100Yrs) |
7.398800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.847800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.958400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.059800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.781600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.128600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.687000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.832590E-01 |
| Classical-VS-Follicular |
1.90970000035762E-07 |
| Classical-VS-Other |
2.948000E-01 |
| Classical-VS-Normal |
1.51739999998401E-06 |
| Tall-VS-Follicular |
7.868300E-02 |
| Tall-VS-Other |
7.143200E-01 |
| Tall-VS-Normal |
1.648610E-01 |
| Follicular-VS-Other |
5.422000E-01 |
| Follicular-VS-Normal |
3.073000E-01 |
| Other-VS-Normal |
8.012000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.552600E-01 |
| Normal-vs-N1 |
1.370810E-01 |
| N0-vs-N1 |
4.270000E-01 |
|
|
